Astrana Health (NASDAQ:ASTH – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37), Zacks reports. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%.
Astrana Health Stock Down 1.2 %
ASTH stock traded down $0.42 during mid-day trading on Thursday, hitting $34.68. The stock had a trading volume of 235,435 shares, compared to its average volume of 335,343. The company has a fifty day moving average of $35.01 and a 200 day moving average of $44.72. Astrana Health has a 1-year low of $29.08 and a 1-year high of $63.20. The stock has a market capitalization of $1.95 billion, a price-to-earnings ratio of 26.68, a PEG ratio of 1.37 and a beta of 1.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.
Analyst Ratings Changes
Several analysts have recently commented on ASTH shares. Truist Financial reduced their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Stifel Nicolaus cut their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Robert W. Baird lifted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $65.60.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- Business Services Stocks Investing
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- 3 Fintech Stocks With Good 2021 Prospects
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.